Position in NVO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$61,971,461
+$16,002,799 QoQ
Shares Held
1,292,688
+3.3% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#48
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 1%
None 1%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $19,386,650,383 across 15 Drug Manufacturers - General names. NVO ranks #13 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,003,417 | $4,801,818,850 | |
| 2 | JNJ |
Johnson & Johnson
|
15,385,556 | $3,907,469,656 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,486,486 | $2,247,013,450 | |
| 4 | ABBV |
AbbVie Inc.
|
7,236,861 | $1,821,083,699 | |
| 5 | NVS |
Novartis AG
|
8,117,586 | $1,272,188,077 | |
| 6 | AMGN |
Amgen Inc
|
3,413,981 | $1,236,270,798 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,691,951 | $1,134,650,214 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,899,794 | $998,059,971 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,971,461 | 1,292,688 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $45,968,662 | 1,250,848 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $67,469,829 | 1,326,058 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $74,281,520 | 1,338,647 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $101,736,997 | 1,474,022 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $102,744,950 | 1,479,622 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $127,633,808 | 1,483,769 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $195,680,113 | 1,643,404 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $231,201,543 | 1,619,739 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $224,487,240 | 1,748,343 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $183,602,954 | 1,774,799 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $161,721,692 | 1,778,334 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $140,237,507 | 866,573 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $134,356,171 | 844,264 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $113,614,139 | 839,472 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $78,169,697 | 784,600 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $84,978,857 | 762,621 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $82,130,914 | 739,585 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $82,060,384 | 732,682 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $68,695,539 | 715,504 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $59,897,979 | 715,029 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $49,524,372 | 734,565 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $51,876,128 | 742,679 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $51,541,846 | 742,357 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $48,903,868 | 746,852 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $44,960,490 | 746,852 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||